Board of directors

Our board of directors brings diverse perspectives, skills and areas of expertise important to fostering the company's business success. The board is dedicated to effective oversight of the business and the key risks facing the company.

Robert M. Davis

Douglas M. Baker, Jr.

Mary Ellen Coe

Pamela J. Craig

Thomas H. Glocer

Risa J. Lavizzo-Mourey, M.D.

Stephen L. Mayo, Ph.D.

Paul B. Rothman, M.D.

Patricia F. Russo

Christine E. Seidman, M.D.

Inge G. Thulin

Kathy J. Warden

Peter C. Wendell

Dates prior to the merger of Merck & Co., Inc. (“Merck”) and Schering-Plough Corporation (“Schering-Plough”) on November 3, 2009, reflect membership on the board of legacy Merck (Glocer and Wendell) or legacy Schering-Plough (Russo), as the case may be.